Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 15 Mar 2024: Hansoh Pharma and Biotheus strengthen collaboration on EGFR/cMET Bispecific ADC development Biotheus and Hansoh Pharma expand strategic collaboration for antibody-drug conjugate (ADC) development Hansoh Pharma gains exclusive […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 13 Mar 2024: Zai Lab Unveils Breakthrough ADC ZL-1310 for Solid Tumor Treatment Zai Lab to present preclinical study findings on ZL-1310 at ELCC 2024 ZL-1310 is a novel ADC […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 12 Mar 2024: Pfizer eyes Adcetris Expansion into Large B-Cell Lymphoma following successful trial Adcetris, a Pfizer’s ADC, secures the first pivotal trial victory from the legacy Seagen portfolio post-merger, […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 08 Mar 2024: T-DXd (Enhertu) exhibits intracranial activity in HER2+ breast cancer brain metastases meta-analysis A systematic review and meta-analysis revealed significant intracranial activity of T-DXd (Enhertu) in HER2+ breast […]
